Nanalysis Scientific Corp.
NSCIF
$0.1858
$0.00040.22%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.84% | 21.87% | 47.73% | 61.94% | 139.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.84% | 21.87% | 47.73% | 61.94% | 139.58% |
| Cost of Revenue | -15.99% | -2.53% | 35.90% | 30.57% | 87.19% |
| Gross Profit | 8.43% | 136.61% | 89.53% | 323.10% | 5,129.68% |
| SG&A Expenses | -2.07% | -5.44% | -8.17% | -7.94% | -19.03% |
| Depreciation & Amortization | -25.56% | 5.12% | 0.63% | -6.65% | -5.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.89% | -1.25% | 16.92% | 14.11% | 33.63% |
| Operating Income | 41.35% | 116.57% | 63.14% | 72.83% | 65.68% |
| Income Before Tax | 53.14% | -537.03% | 74.82% | 55.01% | 48.32% |
| Income Tax Expenses | 525.42% | -102.67% | 102.44% | 98.11% | 101.43% |
| Earnings from Continuing Operations | 51.32% | -241.14% | 74.28% | 51.69% | 41.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.32% | -241.14% | 74.28% | 48.88% | 36.03% |
| EBIT | 41.35% | 116.57% | 63.14% | 72.83% | 65.68% |
| EBITDA | -51.42% | 134.21% | 52.92% | 69.88% | 85.22% |
| EPS Basic | 55.80% | -205.84% | 76.84% | 55.05% | 41.42% |
| Normalized Basic EPS | 54.72% | 73.74% | 57.52% | 57.80% | 49.76% |
| EPS Diluted | 55.80% | -205.84% | 68.18% | 51.01% | 41.42% |
| Normalized Diluted EPS | 54.72% | 73.74% | 57.52% | 57.80% | 49.76% |
| Average Basic Shares Outstanding | 9.65% | 11.47% | 11.51% | 13.94% | 9.26% |
| Average Diluted Shares Outstanding | 9.65% | 11.47% | 11.51% | 13.94% | 9.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |